Department of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Peking University, Beijing, China.
Tasly Microcirculation Research Center, Peking University Health Science Center, Beijing, China.
Shock. 2019 Jun;51(6):745-756. doi: 10.1097/SHK.0000000000001185.
Sirtuin1 (Sirt1) and Sirtuin3 (Sirt3) are known to participate in regulating mitochondrial function. However, whether Total Salvianolic Acid Injection (TSI) protects against myocardial ischemia/reperfusion (I/R) injury through regulating Sirt1, Sirt3, and mitochondrial respiratory chain complexes is unclear. The aim of this study was to explore the effects of TSI on I/R-induced myocardial injury and the underlying mechanism. Male Sprague-Dawley rats were subjected to 30 min occlusion of the left anterior descending coronary artery followed by 90 min reperfusion with or without TSI treatment (8 mg/kg/h). The results demonstrated that TSI attenuated I/R-induced myocardial injury by the reduced infarct size, recovery of myocardial blood flow, and decreased cardiac apoptosis. Moreover, TSI protected heart from oxidative insults, such as elevation of myeloperoxidase, malondialdehyde, hydrogen peroxide, ROS, as well as attenuated I/R-elicited downregulation of Sirt1, Sirt3, NADH dehydrogenase [ubiquinone] 1 alpha subcomplex 10 (NDUFA10), succinate dehydrogenase complex, subunit A, flavoprotein variant (SDHA), and restoring mitochondrial respiratory chain complexes activity. The in vitro study in H9c2 cells using siRNA transfection further confirmed the critical role of Sirt1 and Sirt3 in the effect of TSI on the expression of NDUFA10 and SDHA. These results demonstrated that TSI attenuated I/R-induced myocardial injury via inhibition of oxidative stress, which was related to the activation of NDUFA10 and SDHA through the upregulation of Sirt1 and Sirt3.
Sirtuin1(Sirt1)和 Sirtuin3(Sirt3)已知参与调节线粒体功能。然而,总丹参酸注射液(TSI)是否通过调节 Sirt1、Sirt3 和线粒体呼吸链复合物来保护心肌缺血/再灌注(I/R)损伤尚不清楚。本研究旨在探讨 TSI 对 I/R 诱导的心肌损伤的作用及其潜在机制。雄性 Sprague-Dawley 大鼠接受 30min 左前降支冠状动脉闭塞,然后再灌注 90min,同时给予或不给予 TSI 治疗(8mg/kg/h)。结果表明,TSI 通过减少梗死面积、恢复心肌血流和减少心脏凋亡来减轻 I/R 引起的心肌损伤。此外,TSI 保护心脏免受氧化应激的损伤,如髓过氧化物酶、丙二醛、过氧化氢、ROS 的升高,以及减轻 I/R 引起的 Sirt1、Sirt3、NADH 脱氢酶[泛醌]1 亚基 10(NDUFA10)、琥珀酸脱氢酶复合体、亚单位 A、黄素蛋白变体(SDHA)的下调,并恢复线粒体呼吸链复合物的活性。使用 siRNA 转染的 H9c2 细胞的体外研究进一步证实了 Sirt1 和 Sirt3 在 TSI 对 NDUFA10 和 SDHA 表达的影响中的关键作用。这些结果表明,TSI 通过抑制氧化应激减轻 I/R 诱导的心肌损伤,这与通过上调 Sirt1 和 Sirt3 激活 NDUFA10 和 SDHA 有关。